LAT and cancer: Indeed, the LAT1-specific inhibitor JPH203 (KYT0353) was reported to reduce the incorporation of essential amino acids by cancer cell lines and to attenuate the growth of human tumor cells implanted into nude mice [17], indicating that LAT1 might be an attractive target for cancer therapy.